IL23R and systemic lupus erythematosus: The results described here strongly suggest that SLE patients have a higher frequency of IL-23R+ T lymphocytes in PBMCs, both in CD4+ and CD8+ subsets, than the control group and psoriatic group, and this difference was maintained after ex vivo stimulation.